Share this post on:

Product Name :
Furosemide

Search keywords :
Furosemide

drugId :
null

Target Vo:
Sodium-(potassium)-chloride cotransporter 2

Target Vo Short Name :
NKCC2

Moa_Name:
Sodium-(potassium)-chloride cotransporter 2 inhibitors

First Approval Country :

First Approval Date Filter:
1961

Origin Company_Name :
Sanofi

Active Company_Name :
American University Of Beirut Medical Center

Active Indication_Name:
Heart Failure

In Active Indication_Name:
Nasal Polyps

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Chk1 (Ser296) Antibody
FGFR2 Antibody
Phospho-JAK2 (Tyr1007+Tyr1008) Antibody: Phospho-JAK2 (Tyr1007+Tyr1008) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 131 kDa, targeting to Phospho-JAK2(Y1007+Y1008). It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related